• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GUI Lin.The current situation and analysis on off-label uses of antitumor drug[J].Journal Of Pharmaceutical Research,2015,34(11):664-665,681[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3358times   Download 3773次 QR Code for this article
Scan with your phone!
抗肿瘤药超说明书用药现状与分析
桂琳
Font:Larger+|Default|Smaller-
(中国药科大学,江苏 南京 211198)
摘要:
本文通过收集整理近几年来抗肿瘤药物超说明书用药文献,对超说明书用药产生的原因、发生频率及是否为合理用药进行分析,为抗肿瘤用药提供参考,保障患者用药安全,加强超说明书用药的规范化管理。
关键词:  抗肿瘤药物  超说明书用药  合理用药
DOI:10.13506/j.cnki.jpr.2015.11.015
基金项目:
The current situation and analysis on off-label uses of antitumor drug
GUI Lin
(China Pharmaceutical University,Nanjing 211198,China)
Abstract:
This article collected and sorted out literatures of off-label uses of antitumor drug in recent years,and analyzed the reason,frequency and whether or not was rational use of drug.It can provide reference for antitumor medication to ensure medication safety of patients and enhance the standardized management of off-label drug use.
Key words:  Antitumor drug  Off-label drug use  Rational use of drug
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.